Notes on verification

Directly confirmed by EMA's own annual reporting and independent trade press (RAPS, BioSpace). Minor terminological nuance: EMA figure reflects CHMP recommendations, which the European Commission formally authorizes, but this is a common simplification and doesn't affect the substance. [tier=gold indep_score=0.867 clusters=3 claim_tier=notable | framework convergence=partial on EMA's own 2015 CHMP opinion statistics (upstreams: European Medicines Agency (EMA) 2015 Annual Report, EMA Human Medicines Highlights 2015) — publishers independent, evidence may not be | kind=attributed eligibility=high]